We use cookies to enhance your experience. By continuing to browse this site you agree to our use of cookies. More info.

In a recent study posted to the medRxiv* server, researchers evaluated a rapid antigen test (RAT) that used saliva specimens to detect the presence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

The World Health Organization (WHO) recommends a real-time reverse transcription-polymerase chain reaction (RT-PCR) test that uses nasal/ nasopharyngeal samples as the golden standard for SARS-CoV-2 detection. Qualified personnel perform these tests and require a sophisticated laboratory setup, and their sample preparation and running time is around two hours.

However, due to the limited availability of these tests in several places, self-usable RATs are needed. RATs also potentially reduce the burden on diagnostic laboratories, which increased manifold during the coronavirus disease 2019 (COVID-19) pandemic. Currently, two types of SARS-CoV-2 RATs are available; those that use nasal swabs and the other that uses oral fluid. The latter is gaining interest because it is easier to collect saliva.

In the present study, researchers evaluated a RAT developed by Hangzhou Alltest Biotech that detects SARS-CoV-2 nucleocapsid (NC) protein in human oral fluid specimens. They tested this device on 500 saliva samples self-collected by patients by spitting them into sterile tubes. The researchers ensured that these patients had not consumed food, drink, gum, or tobacco products at least 10 minutes before the sample collection. They performed the test per the instruction manual and obtained results in around 15 minutes.

For every nucleic acid isolation step, the researchers used negative and positive controls, demi water, and independent run control (IRC). Per the manufacturer’s instruction manual, saliva samples with a cycle threshold (CT) value for one or both SARS-CoV-2 NC and open reading frame 1ab (ORF1ab) genes were considered positive.

The study test met the WHO sensitivity criteria in samples with CT values over 30 or high viral loads. It exhibited a sensitivity and specificity of 90.1% and 99.3%, respectively, and an accuracy of 97%. For SARS-CoV-2-positive saliva samples with a CT value lower than 30, its sensitivity and accuracy dropped to 83.8% and 95.9%, respectively. A higher CT value indicates a lower viral load in the sample, which may be difficult for the RAT to detect. Nevertheless, a negative RAT result does not rule out a SARS-CoV-2 infection and requires further verification by RT-PCR.

Furthermore, the RAT required little to no equipment besides the materials provided in its kit. It could be carried easily to a location and performed in less than an hour. Its sample preparation needed less than five minutes, and it fetched results usually within fifteen minutes.

The researchers evaluated a RAT using saliva samples in the current study, which met the high standards set by the WHO and was non-invasive, affordable, and easy to use. It showed an overall sensitivity and specificity of 66.7% and 100% in samples with a CT value lower than 37. It also easily distinguished SARS-CoV-2-infected individuals with high and low viral loads. In support of this study's findings, another study by Basso et al. showed that saliva is an excellent alternative to a nasopharyngeal swab in early SARS-CoV-2 infections.

medRxiv publishes preliminary scientific reports that are not peer-reviewed and, therefore, should not be regarded as conclusive, guide clinical practice/health-related behavior, or treated as established information.

Posted in: Medical Science News | Medical Research News | Disease/Infection News

Tags: Antigen, Coronavirus, Coronavirus Disease COVID-19, covid-19, Diagnostic, Food, Genes, Laboratory, Nasopharyngeal, Nucleic Acid, Pandemic, Polymerase, Polymerase Chain Reaction, Protein, Respiratory, Running, Sample Preparation, SARS, SARS-CoV-2, Severe Acute Respiratory, Severe Acute Respiratory Syndrome, Syndrome, Tobacco, Transcription

Neha is a digital marketing professional based in Gurugram, India. She has a Master’s degree from the University of Rajasthan with a specialization in Biotechnology in 2008. She has experience in pre-clinical research as part of her research project in The Department of Toxicology at the prestigious Central Drug Research Institute (CDRI), Lucknow, India. She also holds a certification in C++ programming.

Please use one of the following formats to cite this article in your essay, paper or report:

Mathur, Neha. (2022, October 13). Evaluating SARS-CoV-2 rapid antigen tests using saliva specimen. News-Medical. Retrieved on November 07, 2022 from https://www.news-medical.net/news/20221013/Evaluating-SARS-CoV-2-rapid-antigen-tests-using-saliva-specimen.aspx.

Mathur, Neha. "Evaluating SARS-CoV-2 rapid antigen tests using saliva specimen". News-Medical. 07 November 2022. <https://www.news-medical.net/news/20221013/Evaluating-SARS-CoV-2-rapid-antigen-tests-using-saliva-specimen.aspx>.

Mathur, Neha. "Evaluating SARS-CoV-2 rapid antigen tests using saliva specimen". News-Medical. https://www.news-medical.net/news/20221013/Evaluating-SARS-CoV-2-rapid-antigen-tests-using-saliva-specimen.aspx. (accessed November 07, 2022).

Mathur, Neha. 2022. Evaluating SARS-CoV-2 rapid antigen tests using saliva specimen. News-Medical, viewed 07 November 2022, https://www.news-medical.net/news/20221013/Evaluating-SARS-CoV-2-rapid-antigen-tests-using-saliva-specimen.aspx.

In this interview, we speak to Victor Wong, Chief Scientific Officer at Core Life Analytics, about their StratoMineRTM product and how it helps researchers to rapidly process their data.

In this interview, we speak to Dr. Steve Ramirez about his latest neuroscience research that investigated the power of our memories.

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.

This site complies with the HONcode standard for trustworthy health information: verify here.

News-Medical.net - An AZoNetwork Site

Owned and operated by AZoNetwork, © 2000-2022